Berman Capital Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3K Hold
25
﹤0.01% 1568
2021
Q2
$3K Hold
25
﹤0.01% 1470
2021
Q1
$3K Hold
25
﹤0.01% 1404
2020
Q4
$2K Hold
25
﹤0.01% 1384
2020
Q3
$1K Sell
25
-6
-19% -$489 ﹤0.01% 1430
2020
Q2
$2K Buy
+31
New +$2.16K ﹤0.01% 1248

Other funds holding CNMD

Berman Capital Advisors's CNMD Position: Q3 2021 in Review

Berman Capital Advisors held its CONMED (CNMD) position steady in Q3 2021 at 25 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

Berman Capital Advisors first reported a position in CNMD in Q2 2020 and has held it in 6 quarters since. 262 funds tracked by Wall St. Rank hold CNMD as of Q3 2021.

  • Berman Capital Advisors held 25 shares of CONMED worth $3K as of Q3 2021.
  • Berman Capital Advisors left its CONMED share count unchanged in Q3 2021.
  • CONMED made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1568 holding.
  • Berman Capital Advisors first reported a position in CONMED in Q2 2020 and has held it in 6 quarters since.
  • 262 funds tracked by Wall St. Rank held CONMED as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.